Overview

Treatment of Hyperuricemia in Patients With Heart Failure

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The study aims to assess (I) the contribution of UA itself to the CHF pathophysiology and (II) to test the effect of lowering UA by uricosuric treatment in CHF.
Phase:
Phase 4
Details
Lead Sponsor:
Tottori University Hospital
Treatments:
Benzbromarone